Home » Newsletters » BioWorld Science

BioWorld Science

May 22, 2008

View Archived Issues

Clinical symptom resolution following therapeutic immunization with oral HCV vaccine

Benznidazole clears parasites, induces CD8+ T-cell memory in Chagas' disease model / News in Context

GlaxoSmithKline's avian influenza virus vaccine candidate safe in children

Ribavirin effective in children with Crimean-Congo hemorrhagic fever

SIRT1 activation shows benefit in murine model of COPD

Topigen's novel multitarget antisense oligonucleotides may be useful for the treatment of asthma

Small molecule targeting microtubules and Bcl-2 effective in prostate cancer xenograft model

Advaxis files IND with FDA for phase II Lovaxin C protocol

BioMarin initiates phase I PEG-PAL study in phenylketonuria

GlobeImmune completes planned enrollment for phase II GI-5005 trial in HCV

Myogane receives orphan medicinal product designation from EMEA

Omeros initiates patient enrollment in phase I OMS-201 study

Telik initiates two phase II Telintra studies

Daiichi Sankyo acquires U3 Pharma for EUR 150 million

SIGA completes screen of small-molecule chemical library in dengue fever antiviral program

Osiris Therapeutics initiates dosing in phase II clinical trial of Prochymal in COPD

FivePrime and Pfizer enter collaboration agreement in oncology and diabetes

Merck & Co. discontinues ACHIEVE imaging study of MK-0524A in HeFH

FDA accepts Anesiva's supplemental NDA filing to expand indication for Zingo

NeoPharm initiates enrollment in phase I clinical trial of LE-DT for metastatic solid cancer

Schering-Plough will initiate two phase III studies of boceprevir in HCV genotype 1

Sunesis initiates REVEAL-1 phase II clinical trial of voreloxin in elderly patients with AML

New antiinflammatory agents disclosed in recent Merck and Kyowa Hakko patents

Novel treatments for diabetes described in recent patent literature

Recent patents report new therapeutic agents for obesity and lipoprotein disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...